Novartis's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; and it has a dividend yield of 3.44%. Novartis is scheduled to report earnings on April 23, 2024, and the estimated EPS forecast is $1.68. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	$ 12.84B	$ 13.09B	$ 12.81B
Gross Profit	-	-	$ 9.04B	$ 9.33B	$ 8.96B
EBIT	-	-	$ 2.13B	$ 2.24B	$ 2.87B
EBITDA	-	-	$ 4.16B	$ 4.05B	$ 4.28B
Net Income Common Stockholders	-	-	$ 1.57B	$ 1.69B	$ 2.22B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 14.43B	$ 143.00M	$ 19.10B	$ 19.76B	$ 18.81B
Total Assets	$ 99.94B	$ 117.45B	$ 118.46B	$ 122.91B	$ 125.22B
Total Debt	$ 20.26B	$ 27.91B	$ 28.54B	$ 31.09B	$ 31.34B
Net Debt	$ 5.84B	$ 27.77B	$ 9.44B	$ 11.33B	$ 12.53B
Total Liabilities	$ 53.20B	$ 58.03B	$ 57.57B	$ 59.90B	$ 63.51B
Stockholders Equity	$ 46.67B	$ 59.34B	$ 60.82B	$ 62.92B	$ 61.54B
Cash Flow	-
Free Cash Flow	-	-	$ 4.14B	$ 3.17B	$ 790.00M
Operating Cash Flow	-	-	$ 4.72B	$ 3.75B	$ 1.65B
Investing Cash Flow	-	-	$ 5.20B	$ -11.63B	$ 9.37B
Financing Cash Flow	-	-	$ -4.74B	$ -2.30B	$ -9.53B

Currency in USD

Novartis Earnings and Revenue History

Income Statement >

Novartis Debt to Assets

Balance Sheet >

Novartis Cash Flow

Cash Flow >

Novartis Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing